Cargando…
Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis
PURPOSE: Cardiac surgery patients always present with atrial fibrillation (AF) after admission to the intensive care unit, leading to high mortality and lengthy hospitalization. Dexmedetomidine (DEX) is a popular medication used for sedation in the intensive care unit; however, whether it can reduce...
Autores principales: | Zhu, Zhipeng, Zhou, Hongmei, Ni, Yunjian, Wu, Cheng, Zhang, Caijun, Ling, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856293/ https://www.ncbi.nlm.nih.gov/pubmed/29559768 http://dx.doi.org/10.2147/DDDT.S153834 |
Ejemplares similares
-
Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials
por: Ling, Xiaoyan, et al.
Publicado: (2018) -
Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress
por: Zhu, Zhipeng, et al.
Publicado: (2020) -
Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress
por: Zhu, Zhipeng, et al.
Publicado: (2021) -
Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial
por: Liu, Xu, et al.
Publicado: (2016) -
Does Dexmedetomidine Reduce the Risk of Atrial Fibrillation and Stroke After Adult Cardiac Surgery? A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Jing, Cuicui, et al.
Publicado: (2022)